Content about Genentech

June 15, 2010
Patient enrollment complete for lung cancer treatment trial

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

June 9, 2010
Michael Catanio honored with award by HDMA

Bayer HealthCare Pharmaceuticals trade relations director Michael Catanio received the Nexus Award for Lifetime Achievement...

June 7, 2010
Astellas completes acquisition of OSI

Japanese drug maker Astellas Pharma has completed its acquisition of OSI Pharmaceuticals, Astellas said Tuesday....

May 18, 2010
Genentech receives FDA approval for Actemra

The Food and Drug Administration has approved a new biotech drug made by Roche U.S....

May 16, 2010
Astellas nabs $4 billion acquisition of OSI

Japanese drug maker Astellas Pharma will acquire U.S.-based OSI Pharmaceuticals for $4 billion, the two...

May 16, 2010
Reporters Notebook

Sandoz got its hands on a collection of generic drug candidates as it agreed to...

May 9, 2010
Genentech, Evotec to collaborate on drug development

U.S. biotechnology company Genentech and German drug maker Evotec hope to develop drugs using Evotec’s...

May 2, 2010
Study: Combination therapy may improve diabetic macular edema

A combination of a biotech drug and laser treatment may improve vision in patients with...

March 11, 2010
Late-stage clinical trial of Avastin fails to meet expectations, Genentech says

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

March 4, 2010
OrbiMed Advisors: Astellas should raise bid for OSI

One of the biggest holders of OSI Pharmaceuticals’ stock has said Japanese drug maker Astellas...

February 28, 2010
Astellas vies for OSI Pharmaceuticals

A Japanese drug maker hopes to buy up a pharmaceutical company based in New York...

February 24, 2010
Genentech reports positive clinical results in Avastin trial

A late-stage clinical trial of a drug by Genentech indicates that combining it with chemotherapy...

February 23, 2010
Report projects breast cancer drug sales to exceed $1 billion

An investigational drug for treating breast cancer will garner sales of more than $1 billion...

February 18, 2010
Rituxan gets nod of approval from FDA

The Food and Drug Administration has approved a drug made by Roche subsidiary Genentech and...

February 17, 2010
Decision Resources projects growth in targeted cancer drug market

The market for drugs that fight cancer by focusing on specific molecules, proteins and enzymes...

January 18, 2010
FDA extends review of lung cancer treatment

The Food and Drug Administration has extended its review period for a lung cancer drug...

January 10, 2010
FDA approves Genentech's new rheumatoid arthritis treatment

The Food and Drug Administration has approved a Genentech drug for treating rheumatoid arthritis, the...

April 9, 2009
FDA warns drug makers about posting ads on search engines

A lot of news has been coming from the Food and Drug Administration lately. And...

A lot of news has been coming from the Food and Drug Administration lately. And that’s almost never good news for the pharmaceutical business.

 

The FDA recently has taken a number of regulatory actions against drug companies on matters ranging from marketing of unapproved drugs, to pulling unsafe drugs from the market, to drug advertising.